Corneal ciprofloxacin precipitation during bacterial keratitis

American Journal of Ophthalmology

Volumn 136, Issue 6, 2003, Pages 1032-1037

  Wilhelmus, Kirk R ^a,c   Abshire, Robert L ^b  

^a CULLEN EYE INSTITUTE   (United States)

^b ALCON RESEARCH LTD   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ADULT; ARTICLE; BACTERIAL KERATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA EPITHELIUM; DISEASE COURSE; EPITHELIZATION; HUMAN; KERATITIS; MEDICAL RECORD; MULTICENTER STUDY; PRECIPITATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; SURFACE PROPERTY;

EID: 0345304332     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)00636-6     Document Type: Article

References (38)

1. Smith A., Pennefather P.M., Kaye S.B., Hart C.A. Fluoroquinolones place in ocular therapy . Drugs. 61:2001;747-761.
2. Leibowitz H.M. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol. 112:(suppl):1991;34S-47S.
3. Parks D.J., Abrams D.A., Sarfarazi F.A., Katz H.R. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol. 115:1993;471-477.
4. Wilhelmus K.R., Hyndiuk R.A., Caldwell D.R., Abshire R.L., Folkens A.T., Godio L.B. 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. Arch Ophthalmol. 111:1993;1210-1218.
5. Tsai A.C., Tseng M.C., Chang S.W., Hu F.R. Clinical evaluation of ciprofloxacin ophthalmic solution in the treatment of refractory bacterial keratitis. J Formos Med Assoc. 94:1995;760-764.
6. Hyndiuk R.A., Eiferman R.A., Caldwell D.R., et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ophthalmology. 103:1996;1854-1863.
7. Prajna N.V., George C., Selvaraj S., Lu K.L., McDonnell P.J., Srinivasan M. Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis. Cornea. 20:2001;175-178.
8. Castillo A., Benitez del Castillo J.M., Toledano N., Diaz-Valle D., Sayagues O., Garcia-Sanchez J. Deposits of topical norfloxacin in the treatment of bacterial keratitis. Cornea. 16:1997;420-423.
9. Konishi M., Yamada M., Mashima Y. Corneal ulcer associated with deposits of norfloxacin. Am J Ophthalmol. 125:1998;258-260.
10. Sinnaeve B.A., Decaestecker T.N., Claerhout I.J., Kestelyn P., Remon J.P., Van Bocxlaer J.F. Confirmation of ofloxacin precipitation in corneal deposits by microbore liquid chromatography-quadrupole time-of-flight tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 785:2003;193-196.
11. Vajpayee R.B., Sharma N., Verma B., et al. Topical pefloxacin in bacterial keratitis. Int Ophthalmol Clin. 22:1998;47-51.
12. Macsai M.S., Goel A.K., Michael M.M., Wall G.M., Sternitzke K.D., Abshire R.L. Deposition of ciprofloxacin, prednisolone phosphate, and prednisolone acetate in SeeQuence disposable contact lenses. CLAO J. 19:1993;166-168.
13. John T. Ciprofloxacin deposits on the cornea and soft contact lens an ultrastructural study . [Abstract] Invest Ophthalmol Vis Sci. 36:1995;S152.
14. John T. Scanning electron microscopic study of a Ciloxan bottle blocked by ciprofloxacin crystals. Eye. 15:2001;786-788.
15. Eiferman R.A., Snyder J.P., Nordquist R.E. Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium. J Cataract Refract Surg. 27:2001;1701-1702.
16. Madhavan H.N., Rao S.K., Joseph P.R., Sulochana K.N. Antibacterial activity of the white precipitate formed on the corneal surface after treatment with ciprofloxacin ophthalmic solution. Cornea. 18:1999;549-552.
17. Essepian J.P., Rajpal R., O'Brien T.P. Tandem scanning confocal microscope analysis of ciprofloxacin corneal deposits in vivo. Cornea. 14:1995;402-407.
18. Insler M.S., Fish L.A., Silbernagel J., Hobden J.A., O'Callaghan R.S., Hill J.M. Successful treatment of methicillin-resistant Staphylococcus aureus keratitis with topical ciprofloxacin. Ophthalmology. 98:1991;1690-1692.
19. Kanellopoulos A.J., Miller F., Wittpenn J.R. Deposition of topical ciprofloxacin to prevent re-epithelialization of a corneal defect. Am J Ophthalmol. 117:1994;258-259.
20. Zhang J., Yu K.F. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 280:1998;1690-1691.
21. Yazdani C., McLaughlin T., Smeeding J.E., Walt J. Prevalence of treated dry eye disease in a managed care population. Clin Ther. 23:2001;1672-1682.
22. Coles W.H., Jaros P.A. Dynamics of ocular surface pH. Br J Ophthalmol. 68:1984;549-552.
23. Williams D.A. Zwitterions and pH-dependent solubility. Am J Health Syst Pharm. 53:1996;1732.
24. Ross D.L., Riley C.M. Aqueous solubilities of some variously substituted quinolone antimicrobials. Int J Pharm. 63:1990;237-250.
25. Yu X., Zipp G.L., Davidson G.W. III. The effect of temperature and pH on the solubility of quinolone compounds estimation of heat of fusion . Pharm Res. 11:1994;522-527.
26. Cervenka P., DeJong D.J., Butler B.L., Monzingo M.D. Visual compatibility of injectable ciprofloxacin lactate with selected injectable drugs during simulated Y-site administration. Hosp Pharm. 27:1992;957-958.
27. Gilbert D.L., Trissel L.A., Martinez J.F. Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration. Am J Health Syst Pharm. 54:1997;1193-1195.
28. Firestone B.A., Dickason M.A., Tran T. Solubility characteristics of three fluoroquinolone ophthalmic solutions in an in vitro tear model. Int J Pharm. 164:1998;119-128.
29. Yamada M., Mochizuki H., Kawai M., Yoshino M., Mashima Y. Fluorophotometric measurement of pH of human tears in vivo. Curr Eye Res. 16:1997;482-486.
30. Lin M.C., Graham A.D., Polse K.A., McNamara N.A., Tieu T.G. The effects of one-hour wear of high-Dk soft contact lenses on corneal pH and epithelial permeability. CLAO J. 26:2000;130-133.
31. Dri P., Presani G., Perticarari S., Alberi L., Prodan M., Decleva E. Measurement of phagosomal pH of normal and CGD-like human neutrophils by dual fluorescence flow cytometry. Cytometry. 48:2002;159-166.
32. Norn M.S. Tear fluid pH in normals, contact lens wearers, and pathological cases. Acta Ophthalmol. 66:1988;485-489.
33. Moreira L.B., Lee R.F., de Oliveira C., LaBree L., McDonnell P.J. Effect of topical fluoroquinolones on corneal re-epithelialization after excimer laser keratectomy. J Cataract Refract Surg. 23:1997;845-848.
34. Mohan M., Sangawe J.L., Mahajan V.M. Pathogenesis of experimentally produced corneal ulcers in rabbits. Ann Ophthalmol. 16:1984;246-252.
35. Patel G.M., Chuang A.Z., Kiang E., Ramesh N., Mitra S., Yee R.W. Epithelial healing rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy. J Cataract Refract Surg. 26:2000;690-694.
36. Miedziak A.I., Miller M.R., Rapuano C.J., Laibson P.R., Cohen E.J. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology. 106:1999;1166-1170.
37. Morlet N., Minassian D., Butcher J. Risk factors for treatment outcome of suspected microbial keratitis. Br J Ophthalmol. 83:1999;1027-1031.
38. Kunimoto D.Y., Sharma S., Garg P., Gopinathan U., Miller D., Rao G.N. Corneal ulceration in the elderly in Hyderabad, South India. Br J Ophthalmol. 84:2000;54-59.